Zemer Gitai: Modeling life's architecture

Credit: Dustin Fenstermacher / Wonderful Machine" /> Credit: Dustin Fenstermacher / Wonderful Machine Zemer Gitai likes to say of his thus far short, but fruitful, science career that he is devolving. Since he studied cancer in mice as an undergraduate student at Massachusetts Institute of Technology, he has been transitioning his work to increasingly simpler biologic systems. For now, he has settled on bacteria. As a PhD student at the University of California, San Fra

Written byAndrea Gawrylewski
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Zemer Gitai likes to say of his thus far short, but fruitful, science career that he is devolving. Since he studied cancer in mice as an undergraduate student at Massachusetts Institute of Technology, he has been transitioning his work to increasingly simpler biologic systems. For now, he has settled on bacteria.

As a PhD student at the University of California, San Francisco, under the tutelage of Cori Bargmann, Gitai worked on axon guidance in Caenorhabditis elegans. In particular, he was interested in the parts of the worm's neurons that "know" when or where to grow, or fire, presumably working through a mechanism controlled by axon guidance and the eukaryotic actin cytoskeleton. But this work became frustrating, Gitai says, as he realized that in such a complex system with so many proteins, finding what controlled spatial cues would be daunting.

Gitai decided that a simpler system would help him get to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies